The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-9957
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol ; volume:7 ; number:1 ; day:14 ; month:11 ; year:2018 ; pages:1-8 ; date:12.2018
Infectious diseases of poverty ; 7, Heft 1 (14.11.2018), 1-8, 12.2018
- Creator
-
Abd-Elfarag, Gasim
Logora, Makoy Yibi
Carter, Jane Y.
Ojok, Morrish
Songok, Jackson
Menon, Sonia
Wit, Ferdinand
Lako, Richard
Colebunders, Robert
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40249-018-0496-2
- URN
-
urn:nbn:de:101:1-2018121723360593371978
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abd-Elfarag, Gasim
- Logora, Makoy Yibi
- Carter, Jane Y.
- Ojok, Morrish
- Songok, Jackson
- Menon, Sonia
- Wit, Ferdinand
- Lako, Richard
- Colebunders, Robert
- SpringerLink (Online service)
Other Objects (12)
High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin